P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION

oleh: M. Heuser, W. Fiedler, A. Block, D. C. de Leeuw, A. van de Loosdrecht, A. Astrid Tschan-Plessl, J. Passweg, A. Kloos, A. Schwarzer, L. Venturini, A. D. Duru, K. Pinkernell, A. Ganser